Los Angeles-based Grifols USA, LLC is a global corporation with manufacturing facilities in that city as well as in Barcelona, Spain, where the company was founded in 1940. It specializes in the production of blood and plasma therapies to treat various life-threatening diseases and conditions.
One of those therapies, AlphaNine® SD Coagulation Factor IX (see photo) is for the prevention and control of bleeding in patients with Factor IX deficiency due to hemophilia B.
















